Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Oragenics Inc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +7 vs. Q2 2021
- Shares held
- 10.7M
- +1.34M (+14.3%) vs. Q2 2021
- Total value
- $6.82M
- +$188.0K (+2.8%) vs. Q2 2021
- New holders
- 8
- 7 more added
- Sold out
- 1
- 3 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $39.2K |
| Q1 2026 | 20 | $105.8K |
| Q4 2025 | 19 | $169.3K |
| Q3 2025 | 16 | $160.5K |
| Q2 2025 | 18 | $401.6K |
| Q1 2025 | 22 | $57.2K |
| Q4 2024 | 24 | $86.0K |
| Q3 2024 | 16 | $62.2K |
| Q2 2024 | 16 | $135.6K |
| Q1 2024 | 14 | $269.2K |
| Q4 2023 | 15 | $349.5K |
| Q3 2023 | 13 | $182.1K |
| Q2 2023 | 13 | $173.5K |
| Q1 2023 | 14 | $192.4K |
| Q4 2022 | 31 | $1.08M |
| Q3 2022 | 29 | $2.48M |
| Q2 2022 | 29 | $3.06M |
| Q1 2022 | 28 | $3.62M |
| Q4 2021 | 33 | $4.96M |
| Q3 2021 | 29 | $6.82M |
| Q2 2021 | 22 | $6.63M |
| Q1 2021 | 29 | $8.27M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Oragenics Inc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 5,052,368 | $3.21M | 0.00% | +20,918+0.4% | Added |
| BlackRock Inc. | 1,307,562 | $830.0K | 0.00% | +1,595+0.1% | Added |
| Sara-Bay Financial | 1,008,117 | $640.0K | 0.25% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 894,205 | $568.0K | 0.00% | +641,641+254.1% | Added |
| Geode Capital Management, LLC | 731,304 | $464.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 458,225 | $291.0K | 0.00% | +3,900+0.9% | Added |
| Virtu Financial LLC | 259,477 | $165.0K | 0.01% | +194,021+296.4% | Added |
| Northern Trust Corp | 181,383 | $115.0K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 163,954 | $104.0K | 0.01% | +163,954 | New |
| FMR LLC | 155,806 | $99.0K | 0.00% | −10.0% | Reduced |
| Bridgeway Capital Management, LLC | 140,000 | $89.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 134,960 | $86.0K | 0.00% | +134,960 | New |
| Price T Rowe Associates Inc | 79,700 | $51.0K | 0.00% | +79,700 | New |
| Jane Street Group, LLC | 55,685 | $35.0K | 0.00% | +55,685 | New |
| Buckingham Strategic Wealth, LLC | 27,000 | $17.0K | 0.00% | +27,000 | New |
| Millennium Management LLC | 17,501 | $11.0K | 0.00% | −9,354−34.8% | Reduced |
| Victory Capital Management Inc | 15,686 | $10.0K | 0.00% | −713−4.3% | Reduced |
| HRT Financial LP | 17,250 | $10.0K | 0.00% | +17,250 | New |
| Spire Wealth Management | 12,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Newman Dignan & Sheerar, Inc. | 10,468 | $7.00K | 0.00% | +10,468 | New |
| Verition Fund Management LLC | 10,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,563 | $4.00K | 0.00% | +2,064+45.9% | Added |
| TSFG, LLC | 3,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Holloway Wealth Management, LLC | – | $1.00K | 0.00% | – | – |
| Wolff Wiese Magana LLC | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 709 | $0 | 0.00% | +77+12.2% | Added |
| Evermay Wealth Management LLC | 120 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 313 | $0 | 0.00% | 00.0% | Unchanged |
| Gerber Kawasaki Wealth & Investment Management | 1 | – | – | +1 | New |
| Bank of America Corp | 0 | $0 | 0.00% | −46−100.0% | Sold out |